mTOR-independent translational control of the extrinsic cell death pathway by RalA

Molecular and Cellular Biology

Volumn 26, Issue 20, 2006, Pages 7345-7357

  Panner, Amith ^a,b,c   Nakamura, Jean L ^c   Parsa, Andrew T ^a,b,c   Rodriguez Viciana, Pablo ^c   Berger, Mitchel S ^a,b,c   Stokoe, David ^a,b,c   Pieper, Russell O ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; BINDING PROTEIN; FLICE INHIBITORY PROTEIN; LIGAND; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN CDC42; PROTEIN RALA; PROTEIN RALBP1; RAL PROTEIN; RAS PROTEIN; S6 KINASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME REPRESSION; GENE ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE RAL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; TRANSLATION REGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; ATP-BINDING CASSETTE TRANSPORTERS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CDC42 GTP-BINDING PROTEIN; CELL DEATH; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; RAL GTP-BINDING PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749603908     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00126-06     Document Type: Article

References (51)

1. Ahmed, I., Y. Calle, S. Iwashita, and A. Nur-E-Kamal. 2006. Role of Cdc42 in neurite outgrowth of PC12 cells and cerebellar granule neurons. Mol. Cell. Biochem. 281:17-25.
2. Allan, L. A., N. Morrice, S. Brady, G. Magee, S. Pathuk, and P. R. Clarke. 2003. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 5:647-654.
3. Bin, L., X. Li, L.-G. Xu, and H.-B. Shu. 2002. The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis. FEBS Lett. 510:37-40.
4. Cantor, S. B., T. Urnao, and L. A. Feig. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol. 15:4578-4584.
5. Chang, G. H.-F., N. M. Barbaro, and R. O. Pieper. 2000. Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro-Oncol. 2:174-183.
6. Chien, Y., and M. A. White. 2003. RAL GTPases and linchpin modulators of human tumor cell proliferation and survival. EMBO Rep. 4:800-806.
7. Chou, M. M., and J. Blenis. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573-583.
8. Coghlan, M. P., M. M. Chou, and C. L. Carpenter. 2000. Atypical protein kinases Cλ and -ζ associate with the GTP-binding protein Cdc42 and mediate stress fiber loss. Mol. Cell. Biol. 20:2880-2889.
9. DeRuiter, N. D., B. M. T. Burgering, and J. L. Bos. 2001. Regulation of the Forkhead transcription factor AFX by Ral-dependent phosphorylation of threonines 447 and 451. Mol. Cell. Biol. 21:8225-8235.
10. Fingar, D. C., C. J. Richardson, A. R. Tee, L. Cheatham, C. Tsou, and J. Blenis. 2004. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24:200-216.
11. Fingar, D. C., and J. Blenis. 2004. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171.
12. Fingar, D. C., S. Salama, C. Tsou, E. Harlow, and J. Blenis. 2002. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4E-BP1/eIF4E. Genes Dev. 16:1472-1487.
13. Gingras, A. C., S. P. Gygi, B. Raught, R. D. Polakiewicz, R. T. Abraham, M. F. Hoekstra, R. Abersold, and N. Sonenberg. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422-1437.
14. Gingras, A. C., B. Raught, and N. Sonenberg. 2001. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807-826.
15. Goi, T., G. Rusanescu, T. Urano, and L. A. Feig. 1999. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth. Mol. Cell. Biol. 19:1731-1741.
16. Gonzalez-Garcia, A., C. A. Pritchard, H. F. Paterson, G. Mavria, G. Stamp, and C. J. Marshall. 2005. RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7:219-226.
17. Guertin, D. A., and D. M. Sabatini. 2005. An expanding role for mTOR in cancer. Trends Mol. Med. 11:353-361.
18. Hamad, N. M., J. H. Elconin, A. E. Karnoub, W. Bao, J. N. Rich, R. T. Abraham, C. J. Der, and C. M. Counter. 2002. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16:2045-2057.
19. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schroter, K. Burns, C. Mattman, D. Rimoldi, L. E. French, and J. Tschopp. 1997. Inhibition of death receptor signals by FLIP. Nature 388:190-195.
20. Johannes, G., and P. Sarnow. 1998. Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA 4:1500-1513.
21. Julien-Flores, V., O. Dorseuil, F. Romero, F. Letourneur, S. Saragosti, R. Berger, A. Tavitian, G. Gacon, and J. H. Camonis. 1995. Bridging Ral GTPase to Rho pathway. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem. 270:22473-22477.
22. Kishida, S., S. Koyama, K. Matsubara, M. Kishida, Y. Matsuura, and A. Kikuchi. 1997. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through RalGDP dissociation stimulator. Oncogene 15:2899-2907.
23. Lim, K.-H., A. T., Baines, J. J. Fiordalisi, M. Shipitsin, L. A. Feig, A. C. Cox, C. J. Der, and C. M. Counter. 2005. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7:533-545.
24. Lowe, S. W., and C. J. Sherr. 2003. Tumour suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13:77-83.
25. Lowe, S. W., E. Cepero, and G. Evan. 2004. Intrinsic tumour suppression. Nature 432:307-315.
26. Martin, K. A., S. S. Schalm, C. Richardson, A. Romanelli, K. L. Keon, and J. Blenis. 2001. Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway. J. Biol. Chem. 276:7884-7891.
27. Matsubara, K., S. Kishida, Y. Matsuura, H. Kitayama, M. Noda, and A. Kikuchi. 1999. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. Oncogene 18:1303-1312.
28. Moskalenko, S., C. Tong, C. Rosse, G. Mirey, E. Formstecher, L. Daviet, J. Camonis, and M. A. White. 2003. Ral GTPases regulate exocyst assembly through dual subunit interactions. J. Biol. Chem. 278:51743-51748.
29. Nesterov, A., M. Nikrad, T. Johnson, and A. S. Kraft. 2004. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-α-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 64:3922-3927.
30. Ohta, Y., N. Suzuki, S. Nakamura, J. H. Harrwig, and T. P. Stossel. 1999. The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. USA 96:2122-2128.
31. S translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol. Cell. Biol. 25:8809-8823.
32. Parsons, M. J., Monypenny, S. M. Ameer-Beg, T. H. Millard, L. M. Machesky, M. Peter, M. D. Keppler, G. Schiavo, R. Watson, J. Chernoff, D. Zicha, B. Vojnovic, and T. Ng. 2005. Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells. Mol. Cell. Biol. 25:1680-1695.
33. S. J. Virol. 77:2651-2662.
34. Polunovsky, V. A., A. C. Gingras, N. Sonenberg, M. Peterson, A. Tan, J. B. Rubins, J. C. Manivel, and P. B. Bitterman. 2000. Translational control of the antiapoptotic function of Ras. J. Biol. Chem. 275:24776-24780.
35. Ponting, C. P., and D. R. Benjamin. 1996. A novel family of Ras-binding domains. Trends Biochem. Sci. 21:422-425.
36. Raught, B., and A. C. Gingras. 1999. eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell. Biol. 31:43-57.
37. Ricci, M. S., Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry. 2004. Direct repression of FLIP expression by e-myc is a major determinant of TRAIL sensitivity. Mol. Cell. Biol. 24:8541-8555.
38. Rodriguez-Viciana, P., and F. McCormick. 2005. RalGDS comes of age. Cancer Cell 7:205-206.
39. Rottmann, S., Y. Wang, M. Nasoff, Q. L. Ceveraux, and K. C. Quon. 2005. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of function. Proc. Natl. Acad. Sci. USA 102:15195-15200.
40. Shay, J. W., and I. B. Roninson. 2004. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919-2933.
41. Shipitsin, M., and L. A. Feig. 2004. RalA hut not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol. Cell. Biol. 24:5746-5756.
42. Sonoda, Y., T. Ozawa, Y. Hirose, K. D. Aldape, M. McMahon, M. S. Berger, and R. O. Pieper. 2001. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res. 61:4956-4960.
43. Stolovich, M., H. Tang, E. Hornstein, G. Levy, R. Cohen, S. S. Bae, M. J. Birnbaum, and O. Meyuhas. 2002. Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation. Mol. Cell. Biol. 22:8101-8113.
44. -/- embryonic stem cells. Mol. Cell. Biol. 25:8465-8475.
45. Ueda, T., R. Watanabe-Fukunaga, H. Fukuyama, S. Nagata, and R. Fukunaga. 2004. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell. Biol. 24:6539-6549.
46. Wang, Y., I. H. Engels, D. A. Knee, M. Nasoff, Q. L. Deveraux, and K. C. Quan. 2005. Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell 5:501-511.
47. Wang, Y., K. C. Quon, and D. A. Knee. 2005. RAS, MYC, and sensitivity to tumor necrosis factor-α-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 65:1615-1617.
48. Wolthius, R. M., and J. L. Bos. 1999. Ras caught in another affair: the exchange factors for Ral. Curr. Opin. Genet. Dev. 9:112-117.
49. Xiao, C., B. F. Yang, L. Li, J. H. Song, H. Schulman, and C. Hao. 2005. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Exp. Cell Res. 304:244-255.
50. Xiao, C., B. F. Yang, N. Asadi, F. Beguinot, and C. Hao. 2002. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by C-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 277:25020-25025.
51. Yadav, S., S. S. Singhal, J. Singhal, D. Wickramarachi, E. Knutson, B. A. Albrecht, Y. C. Awasthi, and S. Awasthi. 2004. Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses. Biochemistry 43:16243-16253.